|
CA2543322A1
|
|
Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
|
|
WO2005000203A2
|
|
Methods for treating cognitive impairment and improving cognition
|
|
MXPA05012614A
|
|
Methods for treating cognitive impairment and improving cognition.
|
|
US2005059743A1
|
|
Methods for treating mild cognitive impairment and alzheimer's disease
|
|
US2005089875A1
|
|
Quantitative analysis of expression profiling information produced at various stages of an amplification process
|
|
WO2004048528A2
|
|
Sampling method and apparatus for amplification reaction analysis
|
|
WO2004003136A2
|
|
Methods of detecting sequence differences
|
|
US2003232890A1
|
|
Methods for treating an impairment in memory consolidation
|
|
EP1490511A2
|
|
Methods and systems for dynamic gene expression profiling
|
|
AU2002353803A1
|
|
Direct resolution of racemic threo-methylphenidate hydrochloride
|
|
AU2002243451A1
|
|
Use of catecholamine reuptake inhibitors to enhance memory
|
|
AU3946402A
|
|
Methods and compositions for regulating memory consolidation
|
|
AU8686101A
|
|
Use of methylphenidate compounds to enhance memory
|
|
AU8532501A
|
|
Use of threo-methylphenidate compounds to enhance memory
|
